| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 07/01/2009 | CN100506803C Polymorph of {6,7-bis(2-methoxy-ethoxy)-quinazolin-4-yl}-(3e) |
| 07/01/2009 | CN100506802C Formyl peptide-like acceptor-1 regulator and its Preparation and use |
| 07/01/2009 | CN100506801C Inhibitors of glycogen synthase kinase 3 |
| 07/01/2009 | CN100506800C Tetrahydropyrimidine-2-one derivatives and their uses |
| 06/30/2009 | US7553976 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 06/30/2009 | US7553971 Aryl aniline β2 adrenergic receptor agonists |
| 06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/30/2009 | US7553876 angiogenesis inhibitors; a salicylamides; amphiphilic compounds; used with various antiinflammatory and cytotoxic agents as well as with radio-therapeutic agents to treat tumor growth and metastasis |
| 06/30/2009 | US7553872 Compounds and compositions for delivering active agents |
| 06/30/2009 | US7553852 Caspase inhibitors and uses thereof |
| 06/30/2009 | US7553840 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
| 06/30/2009 | US7553826 Cytarabine monophosphate prodrugs |
| 06/30/2009 | CA2406088C Novel phenyl-propargylether derivatives |
| 06/30/2009 | CA2330447C N-(3-ethynylphenyl-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate |
| 06/30/2009 | CA2254693C Process for the preparation of aminoalcohol derivatives and their further conversion to (1r,4s)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)amino)-2-cyclopentenyl-1-methanol |
| 06/25/2009 | WO2009079597A1 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 06/25/2009 | WO2009079490A1 Process and intermediates for the synthesis of heterocyclic substituted piperazines with cxcr3 antagonist activity |
| 06/25/2009 | WO2009076747A1 Viral polymerase inhibitors |
| 06/25/2009 | WO2009076743A1 Preparations containing amino acids and orotic acid |
| 06/25/2009 | US20090163712 Processes for preparing hiv reverse transcriptase inhibitors |
| 06/25/2009 | US20090163525 Substituted quinazolines with anti-cancer activity |
| 06/25/2009 | US20090163516 Carboxamides for controlling undesired micro-organisms in plant protection |
| 06/25/2009 | US20090163515 Compounds Which Bind to the Active Site of Protein Kinase Enzymes |
| 06/25/2009 | US20090163496 Antibacterial agents |
| 06/25/2009 | US20090163485 Heteroaryl derivatives as orexin receptor antagonists |
| 06/25/2009 | US20090163463 Organic Compounds |
| 06/25/2009 | US20090163457 Compositions and methods for delivering a biologically active agent |
| 06/25/2009 | US20090160326 Organic electroluminescence material and element using the same |
| 06/25/2009 | DE102007061766A1 New 4-(4-cyano-2-thioaryl)-dihydro-pyrimidinone compounds are human neutrophil elastase inhibitor, useful for the treatment or prevention of e.g. pulmonary arterial hypertonia, acute lung injury and diseases of the cardiovascular system |
| 06/25/2009 | DE102007061757A1 Substituierte 2-Phenylpyrimidin-5-carbonsäuren und ihre Verwendung Substituted 2-phenyl-pyrimidine-5-carboxylic acids and their use |
| 06/25/2009 | DE102007061756A1 Substituierte 4-Aminopyrimidin-5-carbonsäuren und ihre Verwendung Substituted 4-aminopyrimidine-5-carboxylic acids and their use |
| 06/25/2009 | CA2708324A1 Viral polymerase inhibitors |
| 06/24/2009 | EP2072503A2 Process for the preparation of bosentan |
| 06/24/2009 | EP2072502A1 Sulfoximide substituted chinolin and chinazolin derivatives as kinase inhibitors |
| 06/24/2009 | EP1844004B1 Quinazoline derivates as antiviral agents |
| 06/24/2009 | EP1781614B1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 06/24/2009 | EP1611109A4 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 06/24/2009 | EP1483247B1 Aryl substituted pyrimidines and the use thereof |
| 06/24/2009 | CN101463015A Preparation of 5,6,7-trialkoxy-N-aryl substituted-4-amino quinazoline derivative and compound synthesized thereby |
| 06/24/2009 | CN101463014A Diaryl benzo pyridine derivative, and preparation and use thereof |
| 06/24/2009 | CN101463013A Preparation of erlotinid hydrochloride |
| 06/24/2009 | CN101463012A Preparation of gefitinib |
| 06/24/2009 | CN101463011A Process for synthesizing 3,4-dihydropyrimidine-2-keto |
| 06/24/2009 | CN100503600C Pesticidal heterocycles |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503580C Irreversible inhibitor of tyrosine kinase |
| 06/24/2009 | CN100503579C Process for producing substituted aniline compound |
| 06/24/2009 | CN100503578C N-2-pyrimidinyl oxy-benzyl substituted cyclic amine compound, its preparation process and uses |
| 06/24/2009 | CN100503572C Caspase inhibitors and uses thereof |
| 06/24/2009 | CN100503560C Substituted cyclohexane derivatives |
| 06/23/2009 | US7550590 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550473 Pyrimidine derivatives useful as inhibitors of PKC-theta |
| 06/23/2009 | US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases |
| 06/23/2009 | US7550460 2,4-pyrimidinediamine compounds and their uses |
| 06/23/2009 | CA2402991C Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases |
| 06/23/2009 | CA2384354C Pyrimidine derivatives and herbicides containing them |
| 06/23/2009 | CA2214131C Trisubstituted phenyl derivatives |
| 06/18/2009 | WO2009075835A1 CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1 |
| 06/18/2009 | WO2009075277A1 4-aminopyrimidine derivative and medicinal composition containing the compound |
| 06/18/2009 | WO2009075080A1 Fluoroalkylsulfide derivative and pest control agent |
| 06/18/2009 | WO2009074749A2 Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
| 06/18/2009 | WO2009074487A1 Inhibitors of stearoyl-coa desaturase |
| 06/18/2009 | WO2009074333A1 Synthesis of paliperidone |
| 06/18/2009 | WO2009053748A3 Novel crystalline forms |
| 06/18/2009 | WO2009044018A3 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics |
| 06/18/2009 | WO2009036996A3 Small molecule bradykinin b1 receptor antagonists |
| 06/18/2009 | WO2009025919A3 5-propargyl-pyrimidine derivatives as inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties |
| 06/18/2009 | WO2007027532A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 06/18/2009 | US20090156812 Preparations containing amino acids and orotic acid |
| 06/18/2009 | US20090156804 Intermediate compound for synthesizing pharmaceutical agent and production method thereof |
| 06/18/2009 | US20090156622 2,4-pyrimidinediamine compounds and their uses |
| 06/18/2009 | US20090156616 Therapeutic agents |
| 06/18/2009 | US20090156601 kinase inhibitor; immunotherapy; viricides; function or behavior associated with PI3 kinase such as cancer, immune, cardiovascular, nervous system, metabolism/endocrine and neurological diseases, viral infection, inflammation; 2-(3-hydroxyphenyl)-4-(morpholin-4-yl)-6-(pyridin-3-ylmethylamino) pyrimidine |
| 06/18/2009 | US20090155917 Method for analyzing nucleobases on a single molecular basis |
| 06/18/2009 | US20090155787 Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571 |
| 06/18/2009 | CA2708303A1 Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| 06/18/2009 | CA2707105A1 Inhibitors of stearoyl-coa desaturase |
| 06/18/2009 | CA2700559A1 Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
| 06/18/2009 | CA2646795A1 Process for the preparation of bosentan |
| 06/17/2009 | EP2070914A1 New antagonist derivatives of the vitronectin receiver, method for preparing same, application of same as medicine and pharmaceutical compositions containing them |
| 06/17/2009 | EP2069316A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 06/17/2009 | EP2069315A2 Quinazolinone and isoquinolinone acetamide derivatives |
| 06/17/2009 | EP2069314A1 Pyrimidines derivatives and their use as kinase inhibitors |
| 06/17/2009 | EP2069313A2 Metalloprotease inhibitors |
| 06/17/2009 | EP2069305A2 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 06/17/2009 | EP2069289A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS |
| 06/17/2009 | EP2069022A2 Agent for dyeing fibers comprising keratin |
| 06/17/2009 | CN101456845A 4,5-diaryl-2-sulfhydryl miazines compounds and synthetic method thereof and pharmaceutical use |
| 06/16/2009 | US7547782 Met kinase inhibitors |
| 06/16/2009 | US7547781 inhibitors of epidermal growth factor receptor tyrosine kinase and histone deacetylase; 2-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyacetamide; anticarcinogenic agent |
| 06/16/2009 | US7547780 Dihydropteridione intermediate compounds |
| 06/16/2009 | US7547709 Prevent free radical cellular damage; oxidation resistant additive for fuels, lubricants, rubbers, polymers, solvents, chemical and foodstuff; lipid and water soluble vitamin c, vitamin e |
| 06/16/2009 | US7547706 1H-pyrimido[4,5-b]indole derivatives, their preparation and therapeutic use |
| 06/16/2009 | US7547705 Ethyl-1'-[(2S)-2-hydroxy-2-phenylethyl]-6'-oxo-8'-(pyridin-4-yl)-1',3',4',6'-tetrahydro-1H-spiro[piperidine-4,2'-pyrimido[1,2-a]pyrimidine]-1-carbox; glycogen synthase kinase-3 beta, amyloid precursor protein, tau protein hyperphosphorylation inhibitor; neurodegenerative disease, type II diabetes |
| 06/16/2009 | US7547704 Hepatitis C; antivirals; cytosine, uracil or thymine bases on a cyclopentane ring with optional amino acid ester to form hydroxy or phosphate in vivo |
| 06/16/2009 | US7547702 Glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents |
| 06/16/2009 | US7547274 Radioactive member and method of making |
| 06/16/2009 | CA2574904C Antiretroviral enantiomeric nucleotide analogs |
| 06/16/2009 | CA2452217C Hiv inhibiting pyrimidines derivatives |